Clinical Parameters, Routine Inflammatory Markers, and LTA4H Genotype as Predictors of Mortality Among 608 Patients With Tuberculous Meningitis in Indonesia

Autor: Michelle S M A Damen, Jessi Annisa, Tri Hanggono Achmad, Bachti Alisjahbana, Ela Hayati, Lidya Chaidir, Rovina Ruslami, Arjan van Laarhoven, Sofiati Dian, Mihai G. Netea, Reinout van Crevel, Ahmad Rizal Ganiem, Carolien Ruesen
Rok vydání: 2017
Předmět:
Adult
Male
0301 basic medicine
medicine.medical_specialty
Tuberculosis
Genotype
Neutrophils
030106 microbiology
lnfectious Diseases and Global Health Radboud Institute for Molecular Life Sciences [Radboudumc 4]
HIV Infections
Kaplan-Meier Estimate
Disease
Gastroenterology
Tuberculous meningitis
Leukocyte Count
Young Adult
03 medical and health sciences
Cerebrospinal fluid
Internal medicine
Humans
Immunology and Allergy
Medicine
Prospective Studies
Promoter Regions
Genetic

Cerebrospinal Fluid
Proportional Hazards Models
Randomized Controlled Trials as Topic
Epoxide Hydrolases
Inflammation
business.industry
Hazard ratio
Mycobacterium tuberculosis
medicine.disease
Neutrophilia
lnfectious Diseases and Global Health Radboud Institute for Health Sciences [Radboudumc 4]
Infectious Diseases
Indonesia
Tuberculosis
Meningeal

Multivariate Analysis
Cohort
Immunology
Female
medicine.symptom
business
Cohort study
Zdroj: The Journal of Infectious Diseases, 215, 7, pp. 1029-1039
The Journal of Infectious Diseases, 215, 1029-1039
ISSN: 0022-1899
DOI: 10.1093/infdis/jix051
Popis: Contains fulltext : 174715.pdf (Publisher’s version ) (Closed access) Background: Damaging inflammation is thought to contribute to the high morbidity and mortality of tuberculous meningitis (TBM), but the link between inflammation and outcome remains unclear. Methods: We performed prospective clinical and routine laboratory analyses of a cohort of adult patients with TBM in Indonesia. We also examined the LTA4H promoter polymorphism, which predicted cerebrospinal fluid (CSF) leukocyte count and survival of Vietnamese patients with TBM. Patients were followed for >1 year. Results: We included 608 patients with TBM, of whom 67.1% had bacteriological confirmation of disease and 88.2% had severe (ie, grade II or III) disease. One-year mortality was 43.7% and strongly associated with decreased consciousness, fever, and focal neurological signs. Human immunodeficiency virus (HIV) infection, present in 15.3% of patients, was associated with higher mortality and different CSF characteristics, compared with absence of HIV infection. Among HIV-uninfected patients, mortality was associated with higher CSF neutrophil counts (hazard ratio [HR], 1.10 per 10% increase; 95% confidence interval [CI], 1.04-1.16), low CSF to blood glucose ratio (HR, 1.16 per 0.10 decrease; 95% CI, 1.04-1.30), CSF culture positivity (HR, 1.37; 95% CI, 1.02-1.84), and blood neutrophilia (HR, 1.06 per 109 neutrophils/L increase; 95% CI, 1.03-1.10). The LTA4H promoter polymorphism correlated with CSF mononuclear cell count but not with mortality (P = .915). Conclusions: A strong neutrophil response and fever may contribute to or be a result of (immuno)pathology in TBM. Aggressive fever control might improve outcome, and more-precise characterization of CSF leukocytes could guide possible host-directed therapeutic strategies in TBM.
Databáze: OpenAIRE